Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Assets (2016 - 2025)

Marimed has reported Non-Current Assets over the past 13 years, most recently at $143.3 million for Q4 2025.

  • Quarterly Non-Current Assets fell 6.65% to $143.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $586.0 million through Dec 2025, down 4.15% year-over-year, with the annual reading at $143.3 million for FY2025, 6.65% down from the prior year.
  • Non-Current Assets was $143.3 million for Q4 2025 at Marimed, down from $145.5 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $156.0 million in Q3 2024 and troughed at $58.3 million in Q1 2021.
  • The 5-year median for Non-Current Assets is $135.7 million (2023), against an average of $120.2 million.
  • Year-over-year, Non-Current Assets soared 62.13% in 2022 and then decreased 6.73% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $78.6 million in 2021, then skyrocketed by 37.49% to $108.1 million in 2022, then surged by 33.9% to $144.7 million in 2023, then rose by 6.07% to $153.5 million in 2024, then decreased by 6.65% to $143.3 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Non-Current Assets are $143.3 million (Q4 2025), $145.5 million (Q3 2025), and $147.2 million (Q2 2025).